Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New tyrosine kinase inhibitors and their use in proliferative disorders

Dec. 13, 2002

KuDOS and Maybridge claim isoquinoline-based PARP inhibitors

Dec. 13, 2002

Potential use of MLN-518 in AML and high-risk MDS

Dec. 13, 2002

Paladin returns Canadian DepoCyt rights to SkyePharma

Dec. 13, 2002

TLK-286 enters two new combination trials

Dec. 13, 2002

Telomerase inhibitors under study at Pharmacia

Dec. 13, 2002

Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML

Dec. 12, 2002

Exherin cleared to enter phase I trials in Canada

Dec. 12, 2002

NanoCarrier and Kirin collaborate on anticancer therapeutics

Dec. 12, 2002

Apomine as a new therapeutic approach to multiple myeloma

Dec. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...